Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Enzo Health Secures $20 Million Series A to Expand AI Home‑Health Platform
Enzo Health announced a $20 million Series A round led by venture firm N47, bringing its total funding to $26 million. The capital will accelerate the rollout of its AI‑powered platform across home‑health agencies and into skilled‑nursing and hospice settings, addressing a surge in post‑acute care demand.
RevSpring Report: 50% of Consumers Cut Back on Care Due to Financial Confusion and Cost
RevSpring’s national survey of 2,024 U.S. adults finds 94% of consumers want healthcare to be easier to navigate. Roughly 38% struggle to locate an in‑network provider, while 79% are surprised by medical bill prices. Half of respondents admit they cut...
Asembia AXS26: Closing the Gap Between Prescription Fill and Patient Use
Asembia’s AXS26 platform, presented by HealthBeacon GM Kieran Daly, tackles the gap between prescription fill and actual patient use. Traditional metrics track shipments and refills but lack visibility into at‑home administration. AXS26 uses connected in‑home devices that timestamp injections, giving...
Restrictive Cardiomyopathy: The Stiffness You Shouldn't Miss
Restrictive cardiomyopathy (RCM) can cause severe breathlessness despite a normal ejection fraction and thin ventricular walls. The article breaks down four echocardiographic steps—diastolic filling pattern, under‑reported 2D findings, strain imaging, and right‑heart clues—to spot the disease early. By applying these...
From PhD to Regional Medical Director
Jill, a PhD‑trained scientist, now serves as Regional Medical Director (Medical Science Liaison) in Denver, overseeing scientific communication, clinical strategy, and KOL engagement for cancer therapies. Her path moved from postdoc to scientific project manager, then to MSL before attaining...
ADHD Misdiagnosis: Recognizing Hidden Cases Beyond Hyperactive Boys
Why does everyone suddenly have ADHD now? Because we spent decades only recognizing it in hyperactive little boys who couldn't sit still in class. The quiet girl who daydreamed constantly? Missed. The high-achieving adult whose internal world was chaos? Missed. The person who masked...
Do GLP-1 Drugs Like Ozempic Prevent Cancer?
GLP‑1 receptor agonists such as Ozempic, Wegovy, and the newly approved oral drug Foundayo have shown mixed evidence regarding cancer prevention. Some observational studies link them to lower obesity‑related cancer risk and improved survival, while other data show no association...
Obesity Drugs Unlikely to Cause Combined Oral Contraceptive Failure
A systematic review of 10 trials (n=305) examined how GLP‑1 and dual GLP‑1/GIP obesity drugs interact with combined oral contraceptives. The analysis found that ethinyl estradiol exposure remains stable, while progestin levels vary by agent—semaglutide shows minimal change, whereas tirzepatide...
UPMC Reaches Deal with CommonSpirit to Acquire Ohio Health System
UPMC announced a definitive agreement to purchase Trinity Health System, a four‑hospital network with a broad outpatient footprint in Ohio’s Valley. The acquisition gives the Pittsburgh‑based health system its first foothold in Ohio, expanding its mid‑Atlantic presence into the Midwest....
GLP-1s May Not Raise DKA, Pancreatitis Risk in Type 1 Diabetes
A single‑center study of 7,377 adults with type 1 diabetes found that none of the 255 patients using GLP‑1 receptor agonists were hospitalized for diabetic ketoacidosis (DKA) or pancreatitis over a one‑year period. Overall hospital admission rates were significantly lower for...
Oracle Brings AI and Cloud Expertise to Poland's Healthcare
Loved spending a couple days in Poland last week, where I had the privilege of meeting with Tomasz Maciejewski, @USAmbPoland Tom Rose, Hon. Stuart Andrew MP, and other leaders working to advance Poland’s healthcare ecosystem. We at @Oracle are keen to share our...
Dr. Arthur Benjamin: Precision, Innovation, and a Patient-First Vision in Modern Eye Care
Dr. Arthur Benjamin, a board‑certified ophthalmologist and founder of the Benjamin Eye Institute in Los Angeles, brings nearly three decades of experience and more than 30,000 surgeries to his practice. He leads advanced laser vision correction, cataract, and dry‑eye treatments,...
What’s New in Living Kidney Donation, Evaluation and Counseling
A recent review in the Journal of the American Society of Nephrology outlines new practices shaping living kidney donation, including broader use of genetic testing, a race‑neutral eGFR equation, and updated hypertension thresholds. Clinicians are encouraged to initiate donation conversations...
Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update
Disc Medicine reported Q1 2026 results, highlighting the completion of enrollment in its Phase 3 APOLLO trial of bitopertin for erythropoietic protoporphyria, with topline data expected in Q4 2026. The company also announced that Phase 2 data for DISC‑0974 in myelofibrosis‑related anemia will be...
Genetic Variant Determines Individual GLP‑1 Drug Response
As a medical school professor, I get asked why GLP-1 drugs work miracles for some and barely budge for others. A new Nature paper from 23andMe gives part of the answer: your genes. Researchers ran a genome-wide association study in 27,885...
Amulet Capital Taps Adam Grossman as Partner
Amulet Capital announced the promotion of Adam Grossman to partner. In his new role, Grossman will focus on sourcing, structuring, and collaborating with management teams to build and scale healthcare services platforms. The hire strengthens Amulet’s leadership in the rapidly...
ApoB, Not LDL, Predicts True Heart Attack Risk
Lie I was taught in medical school: your LDL cholesterol number is the gold standard for heart attack risk. Reality: a normal LDL with high ApoB is far more dangerous than a "high" LDL with low ApoB. ApoB counts the actual...
Odyssey Therapeutics (ODTX) IPO Deck
Odyssey Therapeutics, a clinical‑stage biopharma specializing in precision medicines for autoimmune and inflammatory disorders, unveiled its initial public offering deck in May 2026. The company aims to raise capital to advance its Phase 2‑tested pipeline, which targets conditions such as rheumatoid...
Mobia Medical (MOBI) IPO Deck
Mobia Medical, a commercial‑stage medical‑device firm, is preparing an initial public offering to fund the next phase of its growth. The company’s flagship technology targets recovery for patients suffering chronic ischemic stroke, a condition affecting millions worldwide. Its device, already...
GMR Solutions (GMRS) IPO Deck
GMR Solutions, a nationwide provider of emergency medical services and out‑of‑hospital care, has released its initial public offering deck ahead of a planned listing. The deck outlines the company’s extensive ambulance fleet, mobile‑critical care units, and partnerships with hospitals and...
Trump Appeal on Vaccines Validates Connecticut's New Immunization Law
The Trump administration appealed a federal court order that blocked its effort to strip vaccine recommendations for flu, rotavirus, hepatitis, meningitis and RSV, a move championed by Robert F. Kennedy Jr. Connecticut responded by passing a law that anchors the...
Pointed Ironies: SERD Wars, ADC Hype, and What Really Works in Breast Cancer
The FDA rejected camizestrant at the ODAC meeting, while approving vepdegestrant a day later. AstraZeneca’s vepdegestrant leverages ctDNA to detect ESR1 mutations early, allowing a treatment switch while patients remain on a CDK4/6 inhibitor backbone. In contrast, Arvinas pursued a...
Abortion Pills Are Saving Women’s Lives. The Right Is Trying to Eliminate Them | Moira Donegan
The U.S. Supreme Court declined to intervene after a federal judge ordered a halt to mailing the abortion pill mifepristone, effectively preserving the ban. The decision follows a wave of state-level abortion restrictions that often lack exceptions for rape, incest,...
Why Lung Cancer Screening Needs Urgent Policy Reform
Nearly 125,000 Americans will be diagnosed with lung cancer this year, yet current screening guidelines block many from early detection. Low‑dose CT scans can lower mortality by 20%, but the USPSTF’s 20‑pack‑year rule and 15‑year quit window exclude high‑risk groups...
New Guideline for Cardiac Ultrasound Artifacts Released by ASE
The American Society of Echocardiography (ASE) has issued a new guideline titled “Recommendations for the Identification and Mitigation of Cardiac Ultrasound Artifacts.” The document provides a systematic approach to recognizing artifacts across 2‑D, Doppler, color and 3‑D echocardiography, complete with...
Exclusive: XCaliber Health Scores $6.5M for Workflow Platform
XCaliber Health announced a $6.5 million seed round to scale its agentic AI platform that automates healthcare administrative tasks. The system ships with pre‑built agents, analytics models and integrates with major EHRs such as Epic, Cerner and athenahealth. CEO Prakash Khot...
What Adding Race to BMI Can Do
Body‑mass index, a 19th‑century height‑weight ratio, remains a cornerstone of obesity and diabetes screening despite its inability to distinguish muscle from fat or locate visceral adiposity. Clinicians have layered race‑based adjustments onto BMI, a practice increasingly criticized because racial categories...
Minerva Neurosciences Provides First Quarter 2026 Financial Results and Business Updates
Minerva Neurosciences announced the start of its global confirmatory Phase 3 trial of roluperidone for negative symptoms of schizophrenia, enrolling about 380 patients across 40 sites, with the first patient screened in March 2026. The company reported a GAAP net loss...
Preoperative Weight Loss May Not Correlate with Risk Reduction
Orthopedic surgeons caution that pre‑operative weight loss may not reduce peri‑operative complications in obese patients. Studies cited show no impact on infection or readmission rates after total joint arthroplasty, and rapid weight loss can increase sarcopenia risk. Mandating BMI cut‑offs...
Benefit Brokers Consider Efficacy of Medical Cannabis
Benefit brokers are evaluating employer reimbursement of medical cannabis as a new health‑benefit option. Platforms such as EM2P2 already provide $100‑$175 per month stipends to cover physician‑authorized cannabis purchases. The recent federal downgrade of cannabis to Schedule III and HHS’s wellness...
What the Harvard ER Study Says About O1 Beating Doctors at Diagnosis, Why It Means Differential Diagnosis Just Stopped Being...
A Harvard‑led Science paper pitted OpenAI’s o1 reasoning model against board‑certified physicians on 76 Boston emergency‑department cases. At the triage stage, o1 achieved roughly 67% diagnostic accuracy versus 50‑55% for doctors, and both groups climbed above 80% once full workup...
The Technology Behind the Story: 3D Skin Grafts and the World of Scarpetta
The article highlights how 3D‑printed skin grafts are transitioning from laboratory experiments to clinical tools for complex wounds. Researchers at Columbia University have demonstrated patient‑specific, three‑dimensional grafts that fit irregular body parts like a glove, reducing surgery time and improving...
AMA Presses Congress for Guardrails on AI Mental Health Chatbots
The American Medical Association is urging Congress to enact stronger safeguards for AI‑enabled mental‑health chatbots, warning that current oversight lags behind rapid adoption. The AMA highlights risks such as misinformation, emotional dependency, privacy breaches, and harmful responses in crisis situations....
Sleep Apnea, Neuropsychiatric Symptoms Linked in Football Players
A new analysis of the Football Players Health Study found that roughly 69% of former professional football players likely have obstructive sleep apnea, yet only about one‑third have a formal diagnosis. Those with diagnosed but untreated sleep apnea exhibited the...
Part 2, Trump Admin Invites Destruction of MAHA in Court!
The Justice Department has filed an appeal backing medical groups that sued the Department of Health and Human Services and former HHS Secretary Xavier Becerra over vaccine decisions made during the Kennedy administration. The appeal upholds a judge’s order that...
Male‑dominant Dementia Risks Highlighted in 2024 Lancet Report
Broadening dementia risk models: building on the 2024 Lancet Commission report for a more inclusive global framework Your dementia risk profile may differ by sex. Which risk factors matter most for you? 🤔👇👨⚕️ "The 2024 report identifies 14 modifiable risk factors for...
Myqorzo ACACIA Study Achieves Dual Primary Endpoint Success
$CYTK Here we go! Myqorzo ACACIA study results in nHCM --> BOTH co-primary endpoints hit with statistical significance. There may be debate about magnitude of improvements for Myqorzo via KCCQ-CSS and peak V02. But, if you were dreaming for a...
STAT+: Cytokinetics Drug Myqorzo Meets Twin Efficacy Goals in Study of Genetic Heart Disease
Cytokinetics announced that its Phase 3 ACACIA trial met both primary efficacy endpoints for Myqorzo in patients with non‑obstructive hypertrophic cardiomyopathy, showing significant symptom relief and improved cardiovascular fitness. Myqorzo is already approved for the obstructive form of HCM, and this...
Historical Perspective on Competition and Regulation in Health Services
Professor Paul Ginsberg’s essay in the Journal of Economic Perspectives traces how competition and regulation have shaped U.S. health‑care financing since Medicare and Medicaid began in the mid‑1960s. Early on, competition was viewed skeptically because physicians dominated care and low...
Patents Hide Life‑Saving Drug Clues Await Discovery
What if the next life-saving drug is buried in a patent diagram? In early drug discovery, progress can hinge on a single decision. The evidence exists, but some of the most valuable insights stay invisible to conventional search, especially inside...
Few Hospitals Rely on Gifts; Most Earn Fees
My analysis of IRS data found only 10 hospitals (out of 2,100) that received more than 50% of their income from gifts. The typical nonprofit hospital receives 94% of its income from fee-for-service payments and just 3% from gifts. This $1.3...
HHS Unveils MAHA Action Plan to Slash Antidepressant Overprescribing
HHS Secretary Robert F. Kennedy Jr. announced a federal MAHA Action Plan aimed at curbing the overprescribing of psychiatric medications, with a focus on antidepressants for children. The initiative promises new guidelines, education campaigns, and a study linking antidepressants to...
Tech Disruption Varies by Specialty: Task Type Matters
An analysis of what impact digital technologies could have on the top 20 medical specialties, based on how repetitive vs creative and interaction-based vs data-based tasks those specialties entail. This and many more inforaphics and detailed analyses in our e-book: The...
Gallium Needle Softens at Body Heat, Boosts Injection Safety
KAIST Develops Gallium Needle That Softens at Body Temperature for Safer Injections by @tweetciiiim #MedTech #HealthTech #Tech #TechForGood https://t.co/g8iTdzNeF9
New Handbook Review Positions Creatine as Brain‑Health Aid, Not a Steroid
Dr. Mehdi Boroujerdi’s upcoming Handbook of Creatine and Creatinine In Vivo Kinetics, releasing May 12, argues that creatine supports cognitive function and is not a steroid. The review cites anti‑inflammatory, antioxidant, and energy‑regeneration properties, prompting calls for broader dietary‑supplement guidance.
Agents Without Moats Will Falter in Fierce Market
Pointed ironies in the SERD wars, plus ADC hype, and what really works in breast cancer... How agents with no moat, no differentiation, and no clear advantage will struggle in a tough competitive market: https://t.co/2Efcy5ItNM https://t.co/FBDM2eDJd4
Singapore Launches Largest Parenting Trial to Test Sensitive Caregiving
Singapore has kicked off the LOVING study, the nation’s largest parenting randomised controlled trial, recruiting 624 families to evaluate video‑feedback coaching that strengthens sensitive caregiving. The trial, backed by NUS, A*STAR and KK Women’s Hospital, seeks to link parental responsiveness...
How GLP-1 Medications Shift Modern Weight-Loss Trends
GLP‑1 medications are rapidly becoming the dominant tool for weight loss, especially among young adults, as cultural preferences swing back toward a thinner, early‑2000s‑style ideal. The surge in prescriptions coincides with a social‑media‑driven “quick‑fix” narrative that often omits the need...
Slow Alzheimer’s Diagnoses ‘Mean UK Patients Missing Out on Experimental Treatments’
Alzheimer's Research UK warns that delayed or imprecise diagnoses are keeping UK patients out of a surge of experimental drug trials. While global trials hit a record 192 this year, fewer than 1,000 UK participants are enrolled in phase‑3 studies....
NHS to Roll Out ‘1-Minute’ Immunotherapy Jab to Tens of Thousands with Cancer
The NHS is introducing a sub‑cutaneous form of pembrolizumab (Keytruda) that can be administered in just one minute, replacing the traditional two‑hour IV infusion. The rapid jab is approved for 14 cancer types, including lung, breast, head‑and‑neck, and cervical cancers,...